Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
PaperCitations, authors & open-access status
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,654 citations, 2014 year and bronze oa status.
1,654
Citations
2014
Year
bronze
OA Status